openPR Logo
Press release

Coronary Stents Market Size is Expected to Surpass US$ 25.7 Billion Through 2028| Transparency Market Research Inc.

02-26-2024 09:24 AM CET | Health & Medicine

Press release from: Transparency Market Research

Coronary Stents

Coronary Stents

The global ๐œ๐จ๐ซ๐จ๐ง๐š๐ซ๐ฒ ๐ฌ๐ญ๐ž๐ง๐ญ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ, valued at US$ 10.1 billion in 2020, is projected to grow at a CAGR of 12.9% from 2021 to 2028, reaching US$ 25.7 billion by the end of 2028.

The increasing prevalence of cardiovascular diseases worldwide, including coronary artery diseases (CADs) and obesity-related issues, is driving this growth, fueled by rising demand from the healthcare sector. Despite these positive trends, challenges such as the high cost of coronary stents, limited reimbursement policies in certain regions, and complications like in-stent restenosis or thrombosis hinder market expansion. Nonetheless, ongoing clinical trials for innovative technologies aim to address these challenges, while emerging economies such as China, India, and Brazil present promising opportunities for market players in the coronary stents industry.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐…:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐จ๐ง ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž-

Abbott Laboratories Inc.,Boston Scientific Corporation,Medtronic Inc.,Johnson & Johnson,Terumo Corporation,B. Braun Melsungen AG,C. R. Bard Inc.,Cook Medical Inc.,AMG International GmbH,Biotronik SE & Co. KG,Stentys SA,and MicroPort Scientific Corporation,among others

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง-

๐๐ซ๐จ๐๐ฎ๐œ๐ญ ๐“๐ฒ๐ฉ๐ž

Bare Metal Stents
Drug Eluting Stents
Bio-absorbable Stents

๐Š๐ž๐ฒ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ-

In September 2021, the U.S. Food and Drug Administration (FDA) approved BIOTRONIK's Orsiro Mission bioabsorbable polymer drug-eluting stent system in September 2021 (BP-DES)

In August 2020, Boston Scientific Corporation's SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System obtained FDA clearance

In January 2016, Abbott paid US$ 25 Bn for St. Jude Medical, Inc. (U.S.), a maker of heart failure,ย atrial fibrillation, andย cardiac rhythm management devices. The acquisition enabled Abbott to boost its coronary intervention product offerings and expand its foothold in the cardiovascular devices industry.

In May 2016, Boston Scientific and Mayo Clinic (USA) teamed up to share intellectual property and accelerate the development of medical devices

๐†๐ž๐ญ ๐“๐ก๐ข๐ฌ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ, ๐ˆ๐ง๐ฌ๐ญ๐š๐ง๐ญ๐ฅ๐ฒ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=23<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ:

Emerging trends shaping the coronary stents market include the development of bioresorbable stents, the adoption of minimally invasive procedures, and the integration of digital health solutions for remote patient monitoring and post-procedural care.

๐‘๐ž๐ ๐ข๐จ๐ง๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ž๐:

North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)

๐Š๐ž๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐ฎ๐๐ฒ ๐๐จ๐ข๐ง๐ญ๐ฌ:

Disease prevalence and epidemiological trends influencing market demand
Technological advancements and their impact on stent performance and patient outcomes
Regulatory landscape and reimbursement policies governing market access and adoption
Competitive landscape analysis, including market players' strategies, product portfolios, and market share

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐Œ๐จ๐ซ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐“๐Œ๐‘:

๐๐จ๐ฎ๐ซ ๐๐จ๐ข๐ง๐ญ ๐ƒ๐ž๐ฉ๐ซ๐ž๐ฌ๐ฌ๐š๐ง๐ญ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2023/05/26/2677306/0/en/Pour-Point-Depressants-Market-Size-is-Expected-to-Surpass-US-2-7-Billion-Through-2031-Transparency-Market-Research-Inc.html

๐๐ง๐ž๐ฎ๐ฆ๐š๐ญ๐ข๐œ ๐๐ž๐›๐ฎ๐ฅ๐ข๐ณ๐ž๐ซ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2023/05/26/2677307/0/en/Pneumatic-Nebulizers-Market-Set-to-Surpass-USD-1-3-Billion-by-2031-with-7-3-of-CAGR-Global-Analysis-by-Transparency-Market-Research.html

๐€๐›๐จ๐ฎ๐ญ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.comย  ย ย  ย ย 
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Coronary Stents Market Size is Expected to Surpass US$ 25.7 Billion Through 2028| Transparency Market Research Inc. here

News-ID: 3398669 • Views: โ€ฆ

More Releases from Transparency Market Research

Functional Coffee Market Expanding at 7.6% CAGR Through 2035 - By Product Type / By Function | Europe โ€ข North America โ€ข Asia Pacific
Functional Coffee Market Expanding at 7.6% CAGR Through 2035 - By Product Type / โ€ฆ
The global functional coffee market was valued at US$ 21.5 Bn in 2024 and is projected to reach US$ 48.1 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2035. This steady growth trajectory reflects the strong convergence of coffee consumption habits with rising demand for functional and wellness-oriented beverages. Functional coffee has transitioned from a niche category to a mainstream product offering,โ€ฆ
Global Electric Face Cleanser Market Poised for Robust Growth, projected to Reach USD 23.6 Billion by 2036 | Transparency Market Research
Global Electric Face Cleanser Market Poised for Robust Growth, projected to Reac โ€ฆ
The global electric face cleanser market is witnessing a transformative growth phase as consumers increasingly integrate advanced skincare technologies into their daily routines. Valued at USD 9.8 billion in 2025, the market is projected to expand significantly and reach USD 23.6 billion by 2036, growing at a healthy compound annual growth rate (CAGR) of 8.6% from 2026 to 2036. This growth trajectory underscores the rising importance of personal care technology,โ€ฆ
Asthma and COPD Drugs Market to Reach US$ 82.2 Billion by 2036, Growing at 5.7% CAGR Driven by Rising Respiratory Disease Burden
Asthma and COPD Drugs Market to Reach US$ 82.2 Billion by 2036, Growing at 5.7% โ€ฆ
The global asthma and COPD drugs market demonstrated strong fundamentals in 2025, with a valuation of US$ 44.7 Bn, reflecting the essential and recurring nature of respiratory therapeutics. Supported by a growing patient base and continuous pharmaceutical innovation, the market is projected to reach US$ 82.2 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2036. This growth trajectory highlights the increasing reliance onโ€ฆ
Low-Alcohol Beverages Market Outlook 2035: Global Industry Set to Expand from US$ 2.1 Bn to US$ 4.6 Bn by 2035 at 7.5% CAGR
Low-Alcohol Beverages Market Outlook 2035: Global Industry Set to Expand from US โ€ฆ
The global low-alcohol beverages market is undergoing a structural transformation as consumers increasingly prioritize health, moderation, and mindful drinking without sacrificing taste or social experiences. Valued at US$ 2.1 billion in 2024, the market is projected to reach US$ 4.6 billion by 2035, expanding at a healthy CAGR of 7.5% from 2025 to 2035. This sustained growth reflects changing lifestyle preferences, generational shifts in alcohol consumption, and continuous innovation byโ€ฆ

All 5 Releases


More Releases for Stent

Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032. What is the Airway Stent/Lung Stent Market and Why is It Significant? The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,โ€ฆ
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lungโ€ฆ
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on anโ€ฆ
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P โ€ฆ
The latestย Globalย Gel Stentย Marketย research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. Theย Gel Stentย market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market.ย There is wide acceptance of Gel Stent across the buyers' segments and this has been driving theโ€ฆ
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas โ€ฆ
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entireโ€ฆ
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patientsโ€ฆ